Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline in the medium- to long-term evolution of leukoaraiosis after acute ischemic stroke
2009-017260-16Phase 2Active
- Sponsor
- Parc de Salut Mar
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in leukoaraiosis (WMH) and ischemic stroke comparing Citicoline arm with Placebo arm (2 arms). Primary endpoints: WMH volume progression on MRI and Medium- to long-term clinical prognosis after stroke. Started Sep 2010; status: active.
02
Drugs
citicoline
03
Conditions
leukoaraiosis (WMH)ischemic stroke
Beyond the preview
Go deeper on 2009-017260-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017260-16.